An Act to Direct the Secretary of Health and Human Services to Support Research on, and Expanded Access to Investigational Drugs for Amyotrophic Lateral Sclerosis, and for Other Purposes

Uniform Title: Accelerating Access to Critical Therapies for ALS Act
Main Author: United States,
Format: eBook
Language: English
Published: [Washington, D.C.] : [U.S. Government Publishing Office], [2021]
Physical Description: 1 online resource (6 unnumbered pages)
Subjects:
Online Access: PDF version
Text version
LEADER 02461nam a2200517 i 4500
001 1291398734
003 OCoLC
005 20220110092528.0
006 m o d f
007 cr |||||||||||
008 220110s2021 dcu ol f000 0 eng c
040 |a GPO  |b eng  |e rda  |e pn  |c GPO  |d GPO  |d MvI 
042 |a pcc 
043 |a n-us--- 
049 |a COM7 
074 |a 0575-A-02 (online) 
086 0 |a AE 2.110:117-79 
088 |a Public Law 117-79 
110 1 |a United States,  |e enacting jurisdiction. 
240 1 0 |a Accelerating Access to Critical Therapies for ALS Act. 
245 1 3 |a An Act to Direct the Secretary of Health and Human Services to Support Research on, and Expanded Access to Investigational Drugs for Amyotrophic Lateral Sclerosis, and for Other Purposes. 
264 1 |a [Washington, D.C.] :  |b [U.S. Government Publishing Office],  |c [2021] 
300 |a 1 online resource (6 unnumbered pages) 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
500 |a "Dec. 23, 2021 (H.R. 3537)." 
500 |a "135 Stat. 1533." 
500 |a "Public Law 117-79." 
500 |a GPO Cataloging Record Distribution Program (CRDP). 
588 |a Description based on online resource; title from PDF title screen (govinfo, viewed on Jan. 10, 2022). 
650 0 |a Amyotrophic lateral sclerosis. 
650 0 |a Federal aid to medical care research  |z United States. 
655 7 |a Statutes and codes.  |2 lcgft. 
776 0 8 |i Print version:  |a United States.  |s Accelerating Access to Critical Therapies for ALS Act.  |t Act to Direct the Secretary of Health and Human Services to Support Research on, and Expanded Access to Investigational Drugs for Amyotrophic Lateral Sclerosis, and for Other Purposes.  |w (OCoLC)1291398375. 
856 4 0 |3 PDF version  |u https://purl.fdlp.gov/GPO/gpo173699  |7 0 
856 4 0 |3 Text version  |u https://purl.fdlp.gov/GPO/gpo173700  |7 0 
907 |a .b65058987  |b cug   |c -  |d 220216  |e 230217 
998 |a cug  |b 220216  |c m  |d a   |e -  |f eng  |g dcu  |h 3  |i 1 
922 |a BIBCONEW  |b 20220110 
948 |a MARCIVE Comprehensive, in 2023.02 
948 |a MARCIVE Over, 03/2022 
995 |a Loaded with m2btab.ltiac in 2023.02 
995 |a Loaded with m2btab.ltiac in 2022.03 
995 |a Loaded with m2btab.msgov7 in 2022.02 
989 |a AE 2.110:117-79  |d cuege  |e  - -   |f  - -   |g j   |h 0  |i 0  |j 216  |k 220216  |l $0.00  |m    |n  - -   |o -  |p 0  |q 0  |t 0  |x 0  |w US Gov Docs  |1 .i14204099x